PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Sherman, Steven I.
TI  - Increased TSH Levels Do Not Affect Safety, Efficacy in Refractory Thyroid Cancer
DP  - 2015 Jun 18
TA  - MD Conference Express
PG  - 15--16
VI  - 15
IP  - 4
4099  - http://mdc.sagepub.com/content/15/4/15.short
4100  - http://mdc.sagepub.com/content/15/4/15.full
AB  - In the SELECT trial, lenvatinib treatment of patients with radioactive iodine 131–refractory differentiated thyroid cancer was associated with increased thyroid-stimulating hormone levels. An exploratory analysis found that worst postbaseline thyroid-stimulating hormone levels were not associated with differences in overall safety, progression-free survival, overall survival, or overall response rate.